je.st
news
Lilly cancer treatment misses key study goal
2013-09-27 01:07:11| Biotech - Topix.net
Shares of Eli Lilly and Co. tumbled in midday trading Thursday after the drugmaker said a potential breast cancer treatment missed its main goal in a late-stage study comparing it to a fake drug.
Tags: key
study
treatment
goal
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||